Q1 2025 Earnings Call Transcript April 22, 2025 Quest Diagnostics Incorporated beats earnings expectations. Reported EPS is ...

Any re-distribution, re-transmission or re-broadcast of this call in any form without written consent ... confidence to confirm Alzheimer's brain pathology in symptomatic patients.

A new technique to mark peripheral pulmonary lesions (PPLs) before surgical resection was studied by Ganesh Krishna, M.D., a ...

Quest Diagnostics reported its Q1 2025 earnings, surpassing market expectations with an adjusted earnings per share (EPS) of $2.21, compared to a forecasted $2.16. Revenue reached 2.65 billion dollars ...

Quest Diagnostics reported its Q1 2025 earnings, surpassing market expectations with an adjusted earnings per share (EPS) of $2.21, compared to a forecasted $2.16. Revenue reached 2.65 billion ...

81-year-old female with a remote history of follicular lymphoma was undergoing evaluation for possible disease recurrence when an incidental right breast mass was identified. 51-year-old female ...

Roche’s move into the digital pathology category has been boosted by FDA approval of a lab instrument and toolkit for use as an aid to clinical diagnosis. The clearance covers Roche’s Ventana ...